Skip to content

ReCode Therapeutics

StartupUS1 field

Website

Where it works

Technology
NanotechnologyDevelops SORT lipid nanoparticles that deliver mRNA and gene correction to specific tissues.

Events

DateEvent
Sep 29, 2025ReCode Therapeutics closes over $29M to advance inhaled mRNA therapiesrecodetx.com· Funding· Nanotechnology

Funding

DateRoundAmount
Sep 29, 2025Additional financing$29M
About
Source
recodetx.com (official, added by seed)
First seen
Sep 25, 2026
Last seen
Sep 25, 2026
DateChange
Sep 25, 2026ReCode TherapeuticsCompany in Nanotechnology: Joined a field, Develops SORT lipid nanoparticles that deliver mRNA and gene correction to specific tissues.
Sep 25, 2026ReCode TherapeuticsCompany: Added

Frontier tech by email

Tuesdays, only in weeks with new milestones, rounds or stage changes in the fields tracked here.

Double opt-in. Unsubscribe any time.